Innoviva Reports Q4 Earnings

Biopharmaceutical company Innoviva posts strong fourth quarter results.

Published on Feb. 25, 2026

Got story updates? Submit your updates here. ›

Innoviva Inc., a biopharmaceutical company based in Burlingame, California, reported net income of $164.2 million in the fourth quarter of 2025.

Why it matters

Innoviva's quarterly earnings are a key indicator of the company's financial health and performance, which is important for investors and the broader pharmaceutical industry.

The details

The company did not provide additional details about its Q4 2025 financial results in the brief Associated Press report.

  • Innoviva reported its Q4 2025 earnings on February 25, 2026.

The players

Innoviva Inc.

A biopharmaceutical company based in Burlingame, California that develops and commercializes medicines.

Got photos? Submit your photos here. ›

The takeaway

Innoviva's strong Q4 earnings demonstrate the company's continued financial success, though more details would be needed to fully assess its performance and outlook.